IRF1 has been noted among the potential drivers of common B cell lymphoid neoplasms and interacts with multiple myeloma oncogene-1 protein (MUM1), which has a role in the progression of B cell lymphoma (71–74). The gene discussed is IRF1; the disease is B-cell non-Hodgkin lymphoma.